methylprednisolone hemisuccinate and Spinal Neoplasms

methylprednisolone hemisuccinate has been researched along with Spinal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anson, J; Gollard, RP; Khoury, J; Mason, J; Rosen, L	1

Other Studies

1 other study(ies) available for methylprednisolone hemisuccinate and Spinal Neoplasms

Article	Year
Intramedullary PNET of the spine: long-term survival after combined modality therapy and subsequent relapse. Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Female; Humans; Methylprednisolone Hemisuccinate; Neuroectodermal Tumors, Primitive; Neuroprotective Agents; Radiotherapy; Spinal Neoplasms; Temozolomide; Thiotepa; Thoracic Vertebrae; Vincristine; Young Adult	2011

Article

Year

Intramedullary PNET of the spine: long-term survival after combined modality therapy and subsequent relapse.

Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Female; Humans; Methylprednisolone Hemisuccinate; Neuroectodermal Tumors, Primitive; Neuroprotective Agents; Radiotherapy; Spinal Neoplasms; Temozolomide; Thiotepa; Thoracic Vertebrae; Vincristine; Young Adult

2011